Updates are available Correction dated 2025-12-30
Click to view Correction: https://doi.org/10.1038/s41598-025-33148-7
-
Authors
Balz, Luisa T. https://orcid.org/0009-0002-8088-3386
Erhart, Deborah K. https://orcid.org/0000-0002-3003-4119
Uttner, Ingo
Lulé, Dorothée E. https://orcid.org/0000-0001-5944-398X
Tumani, Hayrettin https://orcid.org/0000-0002-1647-6201
-
Funding
Funding for this research was provided by:
Universität Ulm
- License Information
-
More Information
Article History
Received: 8 August 2025
Accepted: 21 October 2025
First Online: 18 November 2025
Change Date: 30 December 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-025-33148-7
Declarations
:
: Prof. Dr. Tumani received honoraria for acting as a consultant/speaker and/or for attending events sponsored by Alexion, Bayer, Biogen, Bristol-Myers Squibb, Celgene, Diamed, Fresenius, Fujirebio, GlaxoSmithKline, Horizon, Janssen-Cilag, Merck, Novartis, Roche, Sanofi-Genzyme, Siemens, Teva and Viatris. Prof. Dr. Lulé, PhD received honoraria for acting as a consultant/speaker and/or for attending events sponsored by Zambon. None of the funder(s)/sponsor(s) had any role in the hereby presented study or manuscript. LTB, DKE and, IU declared no conflicts of interest.Prof. Dr. Lulé, PhD received honoraria for acting as a consultant/speaker and/or for attending events sponsored by Zambon. None of the funder(s)/sponsor(s) had any role in the hereby presented study or manuscript. LTB, DKE and, IU declared no conflicts of interest.
: This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Ulm University (Ethics Code: 16/23) on March 16, 2023. All participants provided written informed consent prior to their inclusion in the study.
